Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study.
about
Progesterone acts via the nuclear glucocorticoid receptor to suppress IL-1β-induced COX-2 expression in human term myometrial cellsPrenatal administration of progestogens for preventing preterm birth in women with a multiple pregnancyProphylactic oral betamimetics for reducing preterm birth in women with a twin pregnancyProgestational agents for treating threatened or established preterm labourPrenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birthSpecialised antenatal clinics for women with a pregnancy at high risk of preterm birth (excluding multiple pregnancy) to improve maternal and infant outcomesProgestational agents for treating threatened or established preterm labourProphylactic oral betamimetics for preventing preterm labour in singleton pregnanciesSpecialised antenatal clinics for women with a pregnancy at high risk of preterm birth (excluding multiple pregnancy) to improve maternal and infant outcomesPrenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birthProphylactic oral betamimetics for reducing preterm birth in women with a twin pregnancyProphylactic oral betamimetics for preventing preterm birth in women with a twin pregnancyVaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trialImmunology of term and preterm laborInflammatory aetiology of human myometrial activation tested using directed graphsUse of progesterone and progestin analogs for inhibition of preterm birth and other uterine contractility disordersThe uterine myocyte as a target for prevention of preterm birthVaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM studyBridging progestogens in pregnancy and pregnancy preventionRecent advances in the prevention and management of preterm birthCerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and PreventionProgestin-Containing Contraceptives Alter Expression of Host Defense-Related Genes of the Endometrium and CervixVaginal progesterone, but not 17α-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface.Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis.17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis.Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial.Single nucleotide polymorphisms in the human progesterone receptor gene and spontaneous preterm birth.The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model.Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial.17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats.Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.Bridging the gaps between the histopathological and demographic risk factors of preterm birth in a unique Miami inner-city populationVaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial.Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient dataProgestogens to prevent preterm birth in twin pregnancies: an individual participant data meta-analysis of randomized trials.The role of progesterone in prevention of preterm birth.Cervical strain determined by ultrasound elastography and its association with spontaneous preterm deliveryTrial protocol OPPTIMUM-- does progesterone prophylaxis for the prevention of preterm labour improve outcome?Can antibiotics prevent preterm birth--the pro and con debate.
P2860
Q21090836-83667062-509F-4390-B0AD-85438EE797CBQ24186836-A3440D40-025B-4E2D-817E-823109F00440Q24200651-1BD3AD28-10F2-4523-86A3-5FE07196196DQ24200891-94E5EAC3-3CE5-46FC-9B58-89F4DCFB1BAAQ24200953-CC5A9A53-85EF-4EF5-AA78-1EBE05D5ACB5Q24234443-71DE24B1-669C-4435-90C7-1147B6010BE0Q24240588-FC4E1D1A-36A7-4A03-B5E2-8293508570ADQ24242855-4FB58A50-D37A-4B58-B958-12FD3DFF6D84Q24243748-74690AE8-0858-418A-91BB-0EC5F57F0009Q24244821-F301FC71-1D20-43EC-83A1-D929E3B673E3Q24246616-9169C43B-97C8-4774-BC6E-52A8FDC549BAQ24247273-5D0BBCB3-786F-4E0C-809D-AEEEA20C562DQ24622553-664AD26B-16F8-491F-8FD8-BF0E8539E53BQ24801342-1B0415F0-C6C5-4768-8457-0215DE131928Q24813232-5216527C-353A-4A9C-BE7D-E36255547001Q26862855-28B7E69D-9177-4F70-9291-096B8C52B3DDQ26864122-92A18F60-A39F-4368-A58A-5724547807A3Q28069874-3323FFAD-D732-45D9-A92A-0161A38BAB2FQ28082015-C8968F3E-4C87-4EBC-B653-B1ADCE9C7A15Q28087299-6E0E524F-6CBF-4810-A865-09C36D8445F1Q30235534-E414216E-E839-4FDB-9C12-1C2DE25A5A89Q30358037-E4D204FA-EE15-4EA7-93AD-8F795469689BQ30702434-A85CE136-BF97-4414-9DE8-9D89B5EAA137Q30844080-A648EA5A-C289-4B49-BD85-D95376E35DDEQ31031937-222E52E3-4677-4C82-8B4A-1FC0B412556DQ33288186-FC570FF0-F10E-4155-850E-3DA6705A036FQ33319951-C90BB626-C322-4EC4-BB9A-6A45F5E8D55BQ33341011-E14AB714-357C-4546-AF2C-BBAFF121ED9EQ33412019-48A5882D-3B15-423B-976A-C9AA6F14ADBDQ33607461-CDA94778-51EF-4894-98A1-12B5DFFF0102Q33607661-3703C039-B1B0-4DDC-936B-3BD84424A3F6Q33861248-C254A1E7-225D-42A9-B169-56C19B628C3AQ33916922-CD5E682B-3199-4CFE-A4E9-F7E417D9B7B1Q34113982-2187729A-7A02-4124-AC5B-8B107F2AD094Q34143212-E311391B-E906-4654-AFF6-BED43A2A1389Q34196898-B0BB2EEF-5333-47D9-906E-42816834377CQ34271918-F4ECA044-C557-47E0-91D0-FF8C03ABE76BQ34281817-A78913EF-1D7A-441D-B91E-22B914F60CFAQ34367437-8D3A899B-59C3-4254-9B24-E2BD49F39E76Q34395063-C39DE3C8-7741-4EFE-B59D-CB0DF229C99A
P2860
Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prophylactic administration of ...... controlled double-blind study.
@ast
Prophylactic administration of ...... controlled double-blind study.
@en
Prophylactic administration of ...... controlled double-blind study.
@nl
type
label
Prophylactic administration of ...... controlled double-blind study.
@ast
Prophylactic administration of ...... controlled double-blind study.
@en
Prophylactic administration of ...... controlled double-blind study.
@nl
prefLabel
Prophylactic administration of ...... controlled double-blind study.
@ast
Prophylactic administration of ...... controlled double-blind study.
@en
Prophylactic administration of ...... controlled double-blind study.
@nl
P2093
P356
P1476
Prophylactic administration of ...... controlled double-blind study.
@en
P2093
Eduardo B da Fonseca
Marcelo Zugaib
Mario H B Carvalho
Roberto E Bittar
P304
P356
10.1067/MOB.2003.41
P407
P577
2003-02-01T00:00:00Z